Clinical Trial Update: Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI) [Phase 4]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 4 study evaluating injectable naltrexone for alcohol dependence in individuals with serious mental …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Naltrexone (injectable) (naltrexone)

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED